Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: Distinct fat depots and vascular risk factors

Atherosclerosis

Volumn 239, Issue 2, 2015, Pages 419-427

  Kranendonk, Mariëtte E G ^a   van Herwaarden, Joost A ^a   Stupkova, Tereza ^a   Jager, Wilco de ^a   Vink, Aryan ^a   Moll, Frans L ^a   Kalkhoven, Eric ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Abdominal fat; Adipokines; Adipose tissue; Crown like structures; Insulin resistance; Mesenteric; Metabolic syndrome; Omental; Periaortic; Subcutaneous

Indexed keywords

ADIPOCYTOKINE;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE BIOPSY; AGED; ARTICLE; BIOPSY; BODY MASS; CAPILLARY DENSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL SIZE; CLINICAL ARTICLE; CYTOKINE RELEASE; DIASTOLIC BLOOD PRESSURE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MESENTERIC ADIPOSE TISSUE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTAL ADIPOSE TISSUE; PERIAORTIC ADIPOSE TISSUE; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; ANTHROPOMETRY; BLOOD; CYTOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ABDOMINAL FAT; ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; AGED; ANTHROPOMETRY; BIOPSY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84922677332     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.01.035     Document Type: Article

References (49)

1. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
2. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 2008, 9:367-377.
3. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C., American Heart Association, et al. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
4. Anghel S.I., Wahli W. Fat poetry: a kingdom for PPAR gamma. Cell. Res. 2007, 17:486-511.
5. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J.Clin. Invest 2003, 112:1796-1808.
6. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008, 29:2959-2971.
7. Gealekman O., Guseva N., Hartigan C., Apotheker S., Gorgoglione M., Gurav K., et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011, 123:186-194.
8. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
9. Le K.A., Mahurkar S., Alderete T.L., Hasson R.E., Adam T.C., Kim J.S., et al. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kappaB stress pathway. Diabetes 2011, 60:2802-2809.
10. Wentworth J.M., Naselli G., Brown W.A., Doyle L., Phipson B., Smyth G.K., et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010, 59:1648-1656.
11. Kanhai D.A., Kappelle L.J., van der Graaf Y., Uiterwaal C.S., Visseren F.L., SMART Study Group The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease. Int. J. Obes. (Lond) 2012, 36:695-702.
12. Wassink A.M., van der Graaf Y., van Haeften T.W., Spiering W., Soedamah-Muthu S.S., Visseren F.L., et al. Waist circumference and metabolic risk factors have separate and additive effects on the risk of future type 2 diabetes in patients with vascular diseases. A cohort study. Diabet. Med. 2011, 28:932-940.
13. Verhagen S.N., Wassink A.M., van der Graaf Y., Gorter P.M., Visseren F.L., SMART Study Group Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol. 2011, 10:100. 2840-10-100.
14. Shen W., Wang Z., Punyanita M., Lei J., Sinav A., Kral J.G., et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes. Res. 2003, 11:5-16.
15. Schlett C.L., Massaro J.M., Lehman S.J., Bamberg F., O'Donnell C.J., Fox C.S., et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int. J. Obes. (Lond) 2009, 33:226-232.
16. Nicklas B.J., Penninx B.W., Cesari M., Kritchevsky S.B., Newman A.B., Kanaya A.M., et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the health, aging and body composition study. Am. J. Epidemiol. 2004, 160:741-749.
17. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 2006, 74:443-477.
18. Harman-Boehm I., Bluher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J.Clin. Endocrinol. Metab. 2007, 92:2240-2247.
19. Bremer A.A., Devaraj S., Afify A., Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J.Clin. Endocrinol. Metab. 2011, 96:E1782-E1788.
20. Police S.B., Thatcher S.E., Charnigo R., Daugherty A., Cassis L.A. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1458-1464.
21. Chatterjee T.K., Stoll L.L., Denning G.M., Harrelson A., Blomkalns A.L., Idelman G., et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ. Res. 2009, 104:541-549.
22. Abate N., Garg A. Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog. Lipid Res. 1995, 34:53-70.
23. Faber D.R., Moll F.L., Vink A., van der Waal C., Kalkhoven E., Schipper H.S., et al. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein. Int. J. Obes. (Lond) 2012, 36:1078-1085.
24. Fain J.N. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediat. Inflamm. 2010, 2010:513948.
25. Yang Y.K., Chen M., Clements R.H., Abrams G.A., Aprahamian C.J., Harmon C.M. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell. Physiol. Biochem. 2008, 22:531-538.
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
27. Schipper H.S., de Jager W., van Dijk M.E., Meerding J., Zelissen P.M., Adan R.A., et al. Amultiplex immunoassay for human adipokine profiling. Clin. Chem. 2010, 56:1320-1328.
28. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.
29. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J.Atheroscler. Thromb. 2010, 17:332-341.
30. Dahlman I., Kaaman M., Olsson T., Tan G.D., Bickerton A.S., Wahlen K., et al. Aunique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J.Clin. Endocrinol. Metab. 2005, 90:5834-5840.
31. Karastergiou K., Evans I., Ogston N., Miheisi N., Nair D., Kaski J.C., et al. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1340-1346.
32. Verhagen S.N., Vink A., van der Graaf Y., Visseren F.L. Coronary perivascular adipose tissue characteristics are related to atherosclerotic plaque size and composition. A post-mortem study. Atherosclerosis 2012, 225:99-104.
33. Zhang H., Zhang C. Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am. J. Biomed. Sci. 2009, 1:133-142.
34. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
35. Gambero A., Marostica M., Abdalla Saad M.J., Pedrazzoli J. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm. Bowel Dis. 2007, 13:1357-1364.
36. Desreumaux P., Ernst O., Geboes K., Gambiez L., Berrebi D., Muller-Alouf H., et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999, 117:73-81.
37. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 2007, 56:577-583.
38. Feng Y., Li Y., Mei S., Zhang L., Gong J., Gu L., et al. Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease. Clin. Nutr. 2014, 33:850-858.
39. Ludwig T., Worsch S., Heikenwalder M., Daniel H., Hauner H., Bader B.L. Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E1140-E1156.
40. Evans J., Goedecke J.H., Soderstrom I., Buren J., Alvehus M., Blomquist C., et al. Depot- and ethnic-specific differences in the relationship between adipose tissue inflammation and insulin sensitivity. Clin. Endocrinol. (Oxf) 2011, 74:51-59.
41. Anini Y., Brubaker P.L. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003, 52:252-259.
42. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J.Lipid Res. 2005, 46:2347-2355.
43. O'Connell J., Lynch L., Cawood T.J., Kwasnik A., Nolan N., Geoghegan J., et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010, 5. pp. e9997.
44. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54:2305-2313.
45. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Gyori G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. (Lond) 2007, 31:1420-1428.
46. Martinez F.O., Helming L., Milde R., Varin A., Melgert B.N., Draijer C., et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013, 121:e57-69.
47. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
48. Cancello R., Zulian A., Gentilini D., Maestrini S., Della Barba A., Invitti C., et al. Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity. Obes. (Silver Spring) 2013, 21:2562-2570.
49. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusak J.W., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 2007, 53:766-772.